Skip to content
Screener

Guardian Pharmacy Services GRDN Q2 2026 earnings

Reported August 6, 2026 · After market close

Revenue$351.8MBeat by $11.3M
EPS$0.29Beat by $0.03
Revenue estimate$340.4M
EPS estimate$0.26
“Guardian delivered another strong quarter, with continued momentum across our local markets. While IRA-related pricing reductions affected reported revenue growth, which was up 2%, the underlying business remained strong. Absent the price reductions from the IRA, revenues would have been up low double digits compared to the second quarter of 2025. We also continued to expand profitability, reflecting the benefits of scale, purchasing leverage and improved operating efficiency.”
Fred Burke

Next report

Date not yet announced

Financials

Q2 2026

Income statement

See full
Revenue$351.8M+2.2%
Gross profit$80.0M+17.5%
Operating income$20.6M+64.1%
Net income$21.9M+142%
EPS (diluted)$0.34+143%

Balance sheet

See full
Cash & equivalents$89.8M+377%
Total debt$35.2M+4.6%
Total equity$257.6M+43.4%
Total assets$443.6M+24.5%

Cash flow

See full
Operating cash flow$30.0M+50.6%

Valuation & ratios

Valuation

as of 08/07/26
See full
Market cap$2.5B+88.6%
Enterprise value$2.44B+82.4%
P/E37.9×—
P/S1.7×+0.7×

Profitability

See full
Gross margin21.6%+2.0pp
Operating margin5.8%—
Net margin4.5%+2.8pp

Returns & leverage

See full
Return on equity30.1%—
Debt / equity0.1×-0.1×
Current ratio1.7×+0.5×

Segments

By segment

See full
Corporate$351.8M+2.2%

FAQ

When did Guardian Pharmacy Services report Q2 2026 earnings?
Guardian Pharmacy Services (GRDN) reported Q2 2026 earnings on August 6, 2026 after market close.
What were Guardian Pharmacy Services's Q2 2026 revenue and EPS?
Guardian Pharmacy Services reported revenue of $351.8M and eps of $0.29 for Q2 2026.
Did Guardian Pharmacy Services beat estimates in Q2 2026?
Revenue beat the consensus estimate of $340.4M by $11.3M. EPS beat the consensus estimate of $0.26 by $0.03.
How did Guardian Pharmacy Services's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 2.2% from $344.3M a year earlier and eps grew 26.1% from $0.23.
Where can I find Guardian Pharmacy Services's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-338032) and the 10-Q periodic report (0001193125-26-338074) directly on SEC EDGAR. The filing index links above go to sec.gov.